143 related articles for article (PubMed ID: 11943945)
21. Management of alcoholic liver disease.
Lucey MR
Clin Liver Dis; 2009 May; 13(2):267-75. PubMed ID: 19442918
[TBL] [Abstract][Full Text] [Related]
22. [Correlation between adhesive factors of primary hemostasis and liver fibrogenesis in alcoholic live cirrhosis].
Udvardy M; Hársfalvi J; Pósán E; Káplár M; Katona E; Rák K
Orv Hetil; 1994 Mar; 135(10):523-6. PubMed ID: 8146008
[TBL] [Abstract][Full Text] [Related]
23. Treatment of alcoholic hepatitis with colchicine. Results of a randomized double blind trial.
Trinchet JC; Beaugrand M; Callard P; Hartmann DJ; Gotheil C; Nusgens BV; Lapiere CM; Ferrier JP
Gastroenterol Clin Biol; 1989 Jun; 13(6-7):551-5. PubMed ID: 2753302
[TBL] [Abstract][Full Text] [Related]
24. Alcohol-related liver disease: treatment controversies.
Batey RG
Alcohol Alcohol Suppl; 1994; 2():327-33. PubMed ID: 8974352
[TBL] [Abstract][Full Text] [Related]
25. [Steatosis and fibrosis: first stage of liver damage induced by chronic alcoholism. Our experience in 100 cases].
Mancinella A
Clin Ter; 1991 Apr; 137(1):29-38. PubMed ID: 1828726
[TBL] [Abstract][Full Text] [Related]
26. [The treatment of hepatic cirrhosis with colchicine (preliminary data)].
Nicolaescu T; Bittman E; Stoiculescu P; Udrescu E; Bordeianu A; Bordea M; Gheorghe N; Mogoş I; Vacariu A
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(1):67-74. PubMed ID: 6137048
[No Abstract] [Full Text] [Related]
27. Molecular pathogenesis of alcohol-induced hepatic fibrosis.
Siegmund SV; Brenner DA
Alcohol Clin Exp Res; 2005 Nov; 29(11 Suppl):102S-109S. PubMed ID: 16344593
[TBL] [Abstract][Full Text] [Related]
28. Recent developments in alcoholism:the liver.
Crabb DW
Recent Dev Alcohol; 1993; 11():207-30. PubMed ID: 8234924
[TBL] [Abstract][Full Text] [Related]
29. Hepatic stellate cells and liver retinoid content in alcoholic liver disease in humans.
Hautekeete ML; Dodeman I; Azais-Braesco V; Van den Berg K; Seynaeve C; Geerts A
Alcohol Clin Exp Res; 1998 Apr; 22(2):494-500. PubMed ID: 9581658
[TBL] [Abstract][Full Text] [Related]
30. Alcohol and liver fibrosis.
Cubero FJ; Urtasun R; Nieto N
Semin Liver Dis; 2009 May; 29(2):211-21. PubMed ID: 19387920
[TBL] [Abstract][Full Text] [Related]
31. Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis.
Sørensen TI; Orholm M; Bentsen KD; Høybye G; Eghøje K; Christoffersen P
Lancet; 1984 Aug; 2(8397):241-4. PubMed ID: 6146805
[TBL] [Abstract][Full Text] [Related]
32. Review article: current management of alcoholic liver disease.
Tome S; Lucey MR
Aliment Pharmacol Ther; 2004 Apr; 19(7):707-14. PubMed ID: 15043511
[TBL] [Abstract][Full Text] [Related]
33. Anti-inflammatory and immunosuppressive treatment of alcoholic liver disease.
Juhl E; Christensen E
Acta Med Scand Suppl; 1985; 703():195-9. PubMed ID: 3867241
[No Abstract] [Full Text] [Related]
34. Alcoholic liver disease.
Pimstone NR; French SW
Med Clin North Am; 1984 Jan; 68(1):39-56. PubMed ID: 6361417
[TBL] [Abstract][Full Text] [Related]
35. Failure of colchicine to improve short-term survival in patients with alcoholic hepatitis.
Akriviadis EA; Steindel H; Pinto PC; Fong TL; Kanel G; Reynolds TB; Gupta S
Gastroenterology; 1990 Sep; 99(3):811-8. PubMed ID: 2199290
[TBL] [Abstract][Full Text] [Related]
36. Insights into the pathogenesis of alcoholic liver necrosis and fibrosis: status report.
Tsukamoto H; Gaal K; French SW
Hepatology; 1990 Sep; 12(3 Pt 1):599-608. PubMed ID: 2205558
[TBL] [Abstract][Full Text] [Related]
37. Caffeine protects against alcohol-induced liver fibrosis by dampening the cAMP/PKA/CREB pathway in rat hepatic stellate cells.
Wang Q; Dai X; Yang W; Wang H; Zhao H; Yang F; Yang Y; Li J; Lv X
Int Immunopharmacol; 2015 Apr; 25(2):340-52. PubMed ID: 25701503
[TBL] [Abstract][Full Text] [Related]
38. Colchicine delays the development of hepatocellular carcinoma in patients with hepatitis virus-related liver cirrhosis.
Arrieta O; Rodriguez-Diaz JL; Rosas-Camargo V; Morales-Espinosa D; Ponce de Leon S; Kershenobich D; Leon-Rodriguez E
Cancer; 2006 Oct; 107(8):1852-8. PubMed ID: 16967451
[TBL] [Abstract][Full Text] [Related]
39. Use of colchicine and steroids in the treatment of alcoholic liver disease.
Galambos JT; Riepe SP
Recent Dev Alcohol; 1984; 2():181-94. PubMed ID: 6374780
[TBL] [Abstract][Full Text] [Related]
40. Increased nitric oxide synthesis and inducible nitric oxide synthase expression in patients with alcoholic and non-alcoholic liver cirrhosis.
Sánchez-Rodríguez A; Criado M; Rodríguez-López AM; Esteller A; Martín de Arriba A; López-Novoa JM
Clin Sci (Lond); 1998 Jun; 94(6):637-43. PubMed ID: 9854462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
